Comparison of two methods of lymph node removal in patients suffering from lung cancer
- Conditions
- on-small cell lung cancerCancerNon-small cell lung cancer
- Registration Number
- ISRCTN86637908
- Lead Sponsor
- Jagiellonian University
- Brief Summary
2024 Results article in https://doi.org/10.1186/s13019-024-02928-z (added 04/07/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 500
1. Age =18
2. Proven or suspected NSCLC
3. Clinical stage I, II or minimal N2 IIIA, assessed on the basis of CT, PET-CT (except of T1a-b), bronchoscopy and EBUS/EUS (except of T1a-b)
4. General fitness enabling appropriate pulmonary resection (according to the ERS/ESTS guidelines) (both genders are included, this onfo has been given elsewhere in your on-line form)
1. History of other malignance (except on non-melanoma skin cancer)
2. Final pathological report of tumour other than NSCLC
3. Final pathological report of carcinoid or salivary gland-type tumour
4. Intraoperative finding of M1 disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Overall and cancer-specific 5-year survival rate is measured using the CRF data at 5-year survival is by definition measured 5 years after initiation of the treatment<br>2. DFS is measured using the CRF data at the time of closing the study 5 year after treatment of the last patient included
- Secondary Outcome Measures
Name Time Method 1. Operative time is measured using case report forms at the end of the procedure<br>2. Blood loss is measured using the scale of the suction device container at the end of the procedure<br>3. Pain intensity measured using VAS every 4 hours at the days 0, 1, 2, 3, 4, and 5<br>4. Complications is measured using the CRF data that include records of 45 categories of adverse effects at day of discharge<br>5. Length of hospital stay is measured using hospital records at the day of discharge <br>6. Number of removed lymph nodes in each station is counted by the pathologist during the final pathological examination of the surgical specimen